CBDA Ester Compositions for Stable Multi-Indication Therapy
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing cannabinoid compounds, such as CBDA, are unstable and lack effective therapeutic applications beyond traditional uses, limiting their potential biological and medicinal benefits.
Innovation Solution
Development of cannabinoid acid ester compounds, particularly CBDA esters, which are more stable and provide a range of therapeutic benefits including treatment of joint diseases, skin disorders, gastrointestinal issues, uterine-related disorders, and metabolic conditions, among others, through pharmaceutical compositions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If CBDA is used as a cannabinoid compound, then it can be produced from Cannabis sativa, but it is unstable and lacks effective therapeutic applications
Solution Approach 1:
The patent transforms CBDA into ester derivatives (e.g., CBDA methyl ester, CBDA ethyl ester) by changing its chemical structure. This parameter change in molecular form improves both stability and therapeutic efficacy, allowing the compound to maintain its properties under various conditions and exhibit broader biological activities including anti-inflammatory, analgesic, and neuroprotective effects.
Solution Approach 2:
The patent creates composite cannabinoid compounds by combining CBDA with ester groups (such as methyl ester, ethyl ester, propyl ester). These composite ester derivatives exhibit enhanced stability compared to parent CBDA while demonstrating expanded therapeutic applications across multiple disease states, effectively resolving the contradiction between stability and versatility.
2Reliability
If CBDA is used therapeutically, then it can treat various conditions, but it lacks sufficient stability for effective use
Solution Approach 1:
By converting CBDA into ester forms (methyl ester, ethyl ester, propyl ester), the patent changes the chemical parameters of the compound. This transformation enhances metabolic stability and half-life, allowing the compound to maintain therapeutic efficacy over extended periods and under varying physiological conditions.
Solution Approach 2:
The patent develops ester derivatives that serve as stable, long-lasting therapeutic agents. These ester compounds provide sustained biological activity compared to the short-lived parent CBDA, effectively replacing the need for frequent dosing and enhancing overall therapeutic productivity.
3Adaptability or versatility
If traditional cannabinoid compounds are used, then they have known therapeutic uses, but they are limited in biological activities
Solution Approach 1:
The patent creates universal ester derivative compounds (CBDA methyl ester, CBDA ethyl ester, CBDA propyl ester) that can address multiple therapeutic indications including inflammatory conditions, pain management, neurological disorders, and metabolic diseases. These multi-functional ester compounds demonstrate broader biological activities while maintaining stability, effectively expanding the therapeutic horizon beyond traditional cannabinoid limitations.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The cannabinoid acid esters demonstrate significant therapeutic efficacy in treating various conditions, including osteoarthritis, inflammatory skin diseases, IBS, endometriosis, and metabolic disorders, with improved stability and effectiveness compared to their parent compounds.
Implementation Method 1
CBD can be produced by decarboxylation of CBDA. Due to CBDA's relative instability to decarboxylation
Data Source
AI summary
The present disclosure provides pharmaceutical compositions including a cannabinoid acid ester compound alone or in combination with one or more additional cannabinoid compounds. In some embodiments, the cannabinoid acid ester compound is a cannabidiolic acid ester. A variety of therapeutic applications in which the cannabinoid acid ester compounds and pharmaceutical compositions find use are also provided, including combination therapies using cannabinoid acid ester compounds and one or more additional therapeutic agents.